Osiris Therapeutics, Inc. , the leading stem cell company focused on developing and marketing products in orthopedic, sports medicine and wound care markets announced today its financial results for the third quarter of 2013.
http://www.freshnews.com/news/864995/osiris-reports-3rd-quarter-2013-results-revenue-up-220-strong-balance-sheet-profitable-
http://www.freshnews.com/news/864995/osiris-reports-3rd-quarter-2013-results-revenue-up-220-strong-balance-sheet-profitable-
No comments:
Post a Comment